Welcome to Paid Research Studies


Browse Locations ... United States» ... Massachusetts» ... Cambridge






  • Condition:   Mental Disorders
    Interventions:   Behavioral: DECIDE-PA;   Behavioral: DECIDE-PC
    Sponsors:   Cambridge Health Alliance;   Patient-Centered Outcomes Research Institute (PCORI)
    Recruiting - verified April 2014

  • Condition:   Anterior and Apical Pelvic Organ Prolapse
    Intervention:   Procedure: Prolapse Repair
    Sponsors:   Boston Scientific Corporation;   TEI Biosciences Inc.
    Recruiting - verified April 2014

  • Condition:   Autism Spectrum Disorders
    Interventions:   Drug: Oxytocin;   Behavioral: Social Skills focused CBT;   Behavioral: Stress management/relaxation training;   Drug: placebo drug
    Sponsors:   Massachusetts General Hospital;   Massachusetts Institute of Technology
    Not yet recruiting - verified March 2014

  • Condition:   Uveitis
    Interventions:   Drug: Sarilumab SAR153191/REGN88;   Drug: Prednisone;   Drug: Methotrexate;   Drug: Folic/folinic acid;   Other: Sarilumab (SAR153191/REGN88) placebo
    Sponsors:   Sanofi;   Regeneron Pharmaceuticals
    Recruiting - verified April 2014

  • Condition:   Healthy Adults
    Interventions:   Drug: Syntocinon Nasal Spray, 40IU;   Drug: Syntocinon Placebo Formulation, 40IU
    Sponsors:   Stony Brook University;   Martinos Center for Biomedical Imaging
    Recruiting - verified March 2014

  • Condition:   Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
    Intervention:  
    Sponsors:   Genentech;   Accord Healthcare, Inc.;   Sandoz Inc.;   Apotex Corporation;   Novartis Pharmaceuticals;   Pfizer;   Mylan Pharmaceuticals;   Teva Pharmaceuticals USA;   Alkem Laboratories Ltd;   Roxane Laboratories;   Vintage Pharmaceuticals, LLC
    Recruiting - verified April 2014

  • Conditions:   ADHD;   Attention Deficit Hyperactivity Disorder
    Interventions:   Drug: Naltrexone;   Drug: Placebo
    Sponsor:   Massachusetts General Hospital
    Recruiting - verified February 2014

  • Condition:   Multiple Sclerosis
    Intervention:   Drug: Fingolimod
    Sponsors:   Novartis;   Novartis Pharmaceuticals
    Recruiting - verified March 2014

  • Conditions:   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIC Breast Cancer
    Interventions:   Drug: doxorubicin hydrochloride;   Drug: docetaxel;   Drug: cyclophosphamide;   Biological: trastuzumab;   Drug: paclitaxel;   Other: laboratory biomarker analysis
    Sponsor:   National Cancer Institute (NCI)
    Recruiting - verified December 2013

  • Condition:   Uveitis
    Interventions:   Drug: adalimumab;   Drug: prednisone;   Drug: prednisone;   Drug: adalimumab placebo
    Sponsors:   AbbVie;   AbbVie (prior sponsor, Abbott)
    Recruiting - verified April 2014

  • Condition:   Uveitis
    Interventions:   Drug: adalimumab;   Drug: prednisone;   Drug: adalimumab placebo;   Drug: prednisone
    Sponsors:   AbbVie;   AbbVie (prior sponsor, Abbott)
    Recruiting - verified April 2014

  • Conditions:   Non-Small Cell Lung Cancer;   Anemia;   Cancer;   Lung Cancer
    Interventions:   Drug: darbepoetin alfa 500 mcg Q3W;   Drug: placebo
    Sponsor:   Amgen
    Recruiting - verified March 2014

  • Conditions:   Glycogen Storage Disease;   Pompe Disease
    Intervention:   Biological: alglucosidase alfa
    Sponsors:   Sanofi;   Genzyme, a Sanofi Company
    Recruiting - verified January 2014